نتایج جستجو برای: dentus m2

تعداد نتایج: 44305  

Journal: :Experimental cell research 2009
Gilles A Spoden Ursula Rostek Stefan Lechner Maria Mitterberger Sybille Mazurek Werner Zwerschke

The glycolytic key regulator pyruvate kinase M2 (M2-PK or PKM2) can switch between a highly active tetrameric and an inactive dimeric form. The transition between the two conformations regulates the glycolytic flux in tumor cells. We developed specific M2-PK-binding peptide aptamers which inhibit M2-PK, but not the 96% homologous M1-PK isoenzyme. In this study we demonstrate that, at normal blo...

Journal: :Okajimas folia anatomica Japonica 1998
S Kondo H Hanamura M Natori E Wakatsuki

The maxillary first and second molars (M1 and M2) in the Japanese shrew mole, Urotrichus talpoides, were investigated using an odontometrical approach. The mesiodistal crown diameter was larger in M1 than in M2, while the buccolingual diameter of M1 was nearly equal to that of M2. M2 was more compressed mesiodistally than M1. M1 had a large distal triangle on the stylar shelf. The mesial triang...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1998
M J Millward L K Webster D Rischin K H Stokes G C Toner J F Bishop I N Olver B M Linahan M E Linsenmeyer D M Woodcock

Cremophor EL (cremophor), a component of the paclitaxel formulation, can potentially reverse P-glycoprotein-associated multidrug resistance. A Phase I trial of cremophor as a 6-h infusion every 3 weeks was performed with bolus doxorubicin (50 mg/m2). The cremophor dose was escalated from 1 to 60 ml/m2. A standard paclitaxel premedication was given before cremophor. Using a bioassay, potentially...

2015
YU PENG YUE-E LIU XIAO-CAN REN XUE-JI CHEN HUI-LING SU JIE ZONG ZENG-LI FENG DONG-YING WANG QIANG LIN XIAN-SHU GAO

In this study, the maximum tolerated dose (MTD) of lobaplatin (LBP) when it was combined with docetaxel (TXT) for the treatment of solid tumours that had progressed following chemotherapy was determined, and toxicities to this regimen were evaluated. A modified Fibonacci method was used for the dose escalation of LBP. The patients received TXT (at a fixed dose of 60 mg/m2) on day one (d1) and L...

Journal: :The Biochemical journal 2001
S Sarkar N Miwa H Kominami N Igarashi S Hayashi T Okada S Jahangeer S Nakamura

We have previously reported that a heat-stable activator for ganglioside metabolism, G(M2) activator, potently stimulates ADP-ribosylation factor (ARF)-dependent phospholipase D (PLD) activity (presumably PLD1) in an in vitro system [Nakamura, Akisue, Jinnai, Hitomi, Sarkar, Miwa, Okada, Yoshida, Kuroda, Kikkawa and Nishizuka (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 12249-12253]. However, littl...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2001
D M Kokkinakis D B Bocangel S C Schold R C Moschel A E Pegg

Bis-2-chloroethylnitrosourea (BCNU) or temozolomide (TMZ) were tested alone or in combination with the AGT inhibitors O6-benzyl-2'-deoxyguanosine (dBG) or O6-benzylguanine (BG) against human glial tumor xenografts growing s.c. in athymic mice. Four glioblastoma (SWB77, SWB40, SWB39, and D-54) and one anaplastic oligodendroglioma (SWB61) xenografts having O6-alkylguanine-DNA alkyltransferase (AG...

2017
Wenjun Chen Jianguo Mu Miao Guo

We explored the correlation between smoking, polymorphisms of extracellular superoxide dismutase (ECSOD) and cytochrome P450 (CYP) 1A1-Msp I and the prevalence of oral cancer. The genetic polymorphisms of EC SOD and CYP1A1-Msp I were detected by polymerase chain reaction (PCR) technique in peripheral blood leukocytes of 874 oral cancer patients and 874 non-cancer controls, and the correlations ...

ژورنال: :مجله دانشکده پزشکی اصفهان 0
سید محمد علی علوی اصفهانی کارشناس ارشد، گروه میکرب شناسی، دانشکده ی علوم پایه، دانشگاه آزاد اسلامی، واحد قم، قم، ایران فاطمه فتوحی استادیار، گروه ویروس شناسی، آزمایشگاه تحقیقات آنفلوانزا، انستیتو پاستورایران، تهران، ایران امیر قائمی استادیار، گروه ویروس شناسی پزشکی و ایمنی شناسی، دانشکده ی پزشکی، دانشگاه علوم پزشکی گلستان، گرگان، ایران مریم صالح کارشناس ارشد، گروه ویروس شناسی، آزمایشگاه تحقیقات آنفلوانزا، انستیتو پاستورایران، تهران، ایران سیاوش چلبیانی کارشناس ارشد، گروه میکرب شناسی، دانشکده ی علوم پایه، دانشگاه آزاد اسلامی، واحد قم، قم، ایران بهرخ فرهمند استادیار، گروه ویروس شناسی، آزمایشگاه تحقیقات آنفلوانزا، انستیتو پاستورایران، تهران، ایران معصومه توسطی خیری

مقدمه: پروتئین m2 که یک پروتئین هوموتترامر متصل به غشا با پیوند دی سولفیدی می باشد، در میان همه ی ویروس های آنفلوانزای a به طور کامل حفاظت شده است. به همین دلیل هدف مناسبی برای توسعه ی واکسن آنفلوانزا با محافظت وسیع الطیف می باشد. در این مطالعه پروتئین m2 ویروس آنفلوانزای a در سیستم پروکاریوتی بیان شد. روش ها: ژن پروتئین m2 ویروس آنفلوانزا [a/newcaledonia/20/99 (h1n1)] پس از تکثیر به روش pcr (p...

Journal: :Cell 2003
Michael M. Cox

In this issue of Cell, report on new aspects of the regulation of yeast ribonucleotide reductase, the mechanism by which dNTP levels are increased following DNA damage, and the consequences of the metabolic changes.

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1996
R A Fleming R L Capizzi H B Muss S Smith D J Fernandes H Homesley B W Loggie L Case R Morris G B Russell F Richards

We conducted a combined biochemical modulation trial of N-(phosphonacetyl)-L-aspartate (PALA), dipyridamole (DP), and fluorouracil (5-FU) in patients with cancer. Eighty-eight patients with advanced cancer were entered into this Phase I trial. During the first part of the study, four doses of PALA (125, 250, 500, and 1000 mg/m2, administered on day 1) were evaluated to determine the PALA dose w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید